120 Results for "

Calcium Mobilization

" in MedChemExpress (MCE) Product Catalog:
Products (120)

120 Results for "Calcium Mobilization" in MCE Product Catalog:

Cat. No.: HY-144783
Target:  

CXCR

Research Areas:  

Inflammation/Immunology Cancer

CXCR2 antagonist 6 (compound 35c) is a potent CXCR2 antagonist. CXCR2 antagonist 6 shows potent CXCR2 binding affinity (IC50=0.044 µM) and calcium mobilization (IC50=0.66 µM) [ 1].
loading...
    loading...
Cat. No.: HY-13628A
CAS No.: 152608-41-8
Synonyms: LY293111 sodium; VML 295 sodium
Etalocib (LY293111) sodium, an orally active leukotriene B4 receptor antagonist, inhibits the binding of [ 3H]LTB4, with a Ki of 25 nM. Etalocib sodium prevents LTB4-induced calcium mobilization with an lC50 of 20 nM. Etalocib sodium induces apoptosis .
loading...
    loading...
Cat. No.: HY-118806
CAS No.: 244291-63-2
Target:  

mAChR

Research Areas:  

Neurological Disease

AC-42 is a poent M1 muscarinic selective allosteric agonist with EC50s of 805 nM and 220 nM for human wild-type and Y381A mutated M1 receptors, respectively. AC-42 stimulates the IP-accumulation and calcium mobilization in CHO cells .
loading...
    loading...
Cat. No.: HY-130358
CAS No.: 179469-40-0
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

PDDHV is a calcium absorption inducer and may achieve 45Ca 2+ influx by stimulating vanillic acid receptor VR1. PDDHV induces 45Ca 2+ uptake (EC50: 70 nM) in rat dorsal root ganglion neurons (expressing native vanilloid receptors) and calcium mobilization (EC50: 125 nM) in VR1-transfected CHO cells. PDDHV also inhibits [3H]-resiniferatoxin (RTX) binding to the dorsal root ganglion membrane in rats .
loading...
    loading...
Cat. No.: HY-19198
CAS No.: 150399-22-7
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

SB-201993 is a selective leukotriene B₄ (LTB4) receptor antagonist with a Ki=7.6 nM for LTB4 receptors on human inflammatory cells. SB-201993 inhibits calcium mobilization in inflammatory cells and 5-lipoxygenase activity, exerting anti-inflammatory effects. SB-201993 is promising for research of inflammatory diseases (e.g., dermatitis, arthritis) .
loading...
    loading...
Cat. No.: HY-13628R
CAS No.: 161172-51-6
Synonyms: LY293111 (Standard); VML 295 (Standard)
Etalocib (Standard) is the analytical standard of Etalocib. This product is intended for research and analytical applications. Etalocib (LY293111), an orally active leukotriene B4 receptor antagonist, inhibits the binding of [3H]LTB4, with a Ki of 25 nM. Etalocib (LY293111) prevents LTB4-induced calcium mobilization with an lC50 of 20 nM. Etalocib (LY293111) induces apoptosis .
loading...
    loading...
Cat. No.: HY-141832
CAS No.: 1261171-52-1
Target:  

mGluR

Research Areas:  

Neurological Disease

mGluR5 modulator 1 is a mGluR5 positive allosteric modulator. mGluR5 modulator 1 can be used for the research of the schizophrenia and cognitive impairments .
loading...
    loading...
Cat. No.: HY-N11723
CAS No.: 476-46-0
Synonyms: Katenarin
Catenarin, an anthraquinone compound, inhibits CCR5- and CXCR4-mediated chemotaxis. Catenarin reduces the phosphorylation of mitogen-activated protein kinases (p38 and JNK) and their upstream kinases (MKK6 and MKK7), and calcium mobilization. Catenarin shows anti-inflammatory effect and suppresses leukocyte migration in the diabetes. Catenarin exhibits significant inhibitory effects against Gram-positive bacteria. Catenarin prevents type 1 diabetes (T1D) in nonobese diabetic mice [1][2].
loading...
    loading...
Cat. No.: HY-151392
CAS No.: 2839471-44-0
Purity:  99.62%
LPA5 antagonist 2 (compound 65) is a high aqueous solubility LPA5 (lysophosphatidic acid receptor 5) antagonist. LPA5 antagonist 2 significantly attenuates nociceptive hypersensitivity and it can be used for the research of inflammatory and neuropathic pains .
loading...
    loading...
Cat. No.: HY-160615
CAS No.: 1448452-21-8
TP receptor antagonist-1 (compound 7m) is a thromboxane A2 receptor (TP receptor) antagonist, with IC50 values of 9.46 μM for TPa and 8.49 μM for TPb, respectively. TP receptor antagonist-1 can be used for the research of cardiovascular disease .
loading...
    loading...
Cat. No.: HY-118285
CAS No.: 579482-31-8
Target:  

mGluR

Research Areas:  

Neurological Disease

Ro4491533 is a selective, negative allosteric mGluR2/3 receptor modulator that is equally effective on both subtypes. Ro4491533 can completely block glutamate-induced calcium mobilization and glutamate-induced [35S]GTPγS binding accumulation. Ro4491533 has good pharmacokinetic properties in mice and rats, high oral bioavailability, and can pass through the blood-brain barrier. Ro4491533 can also reverse the motor inhibition effect of LY379268 in mice and show antidepressant activity in the forced swim test and tail suspension test.
loading...
    loading...
Cat. No.: HY-123357
CAS No.: 1456807-80-9
Target:  

Apoptosis

Research Areas:  

Neurological Disease

IMM-H004, a coumarin derivative, possesses neuroprotective and potent free radical scavenging abilities. IMM-H004 significantly inhibits amyloid-β (Aβ)-induced cytotoxicity and apoptosis, offering potential value for research into neurodegenerative diseases such as Alzheimer's disease. Additionally, IMM-H004 is also capable of effectively blocking the calcium mobilization and chemotaxis induced by CKLF1-C27 (HY-P3418), thereby alleviating asthmatic pathological changes in the lung tissue of CKLF1 transgenic mice .
loading...
    loading...
Cat. No.: HY-P2055
CAS No.: 125598-87-0
Target:  

Endogenous Metabolite

Research Areas:  

Endocrinology

A-57696 is a cholecystokinin antagonist with selective activity at cortical CCK-B receptors (IC50 = 25 nM). A-57696 behaves as a competitive antagonist in reversing CCK8-stimulated pancreatic alpha-amylase secretion and phosphatidylinositol degradation. A-57696 fails to induce gallbladder contraction and inhibits CCK8-induced contraction. A-57696 behaves as a partial agonist at CCK-B/gastrin receptors on NCI-H345 cells, achieving 80% of the maximal CCK8 response. A-57696 and CCK8 inhibit each other in a calcium mobilization assay .
loading...
    loading...
Cat. No.: HY-116295
CAS No.: 7077-89-6
MRS2690 is a selective P2Y14 receptor agonist. MRS2690 inhibits adenylyl cyclase activity, thereby reducing intracellular cAMP levels and mediating concentration-dependent vasoconstriction of porcine coronary arteries. MRS2690 induces intracellular calcium mobilization, activates P38 and stimulates [ 35S]GTPγS binding to RBL-2H3 cell membranes. MRS2690 enhances antigen (NP-BSA)-, C3a-induced β-hexosaminidase (β-Hex) release. MRS2690can be used for ischemic heart disease .
loading...
    loading...
Cat. No.: HY-116295A
MRS2690 disodium is a selective P2Y14 receptor agonist. MRS2690 disodium inhibits adenylyl cyclase activity, thereby reducing intracellular cAMP levels and mediating concentration-dependent vasoconstriction of porcine coronary arteries. MRS2690 disodium induces intracellular calcium mobilization, activates P38 and stimulates [ 35S]GTPγS binding to RBL-2H3 cell membranes. MRS2690 enhances antigen (NP-BSA)-, C3a-induced β-hexosaminidase (β-Hex) release. MRS2690 disodium can be used for ischemic heart disease .
loading...
    loading...
Cat. No.: HY-126638
CAS No.: 75731-43-0
Synonyms: NSC 324645
Marcfortine A is an indole alkaloid originally isolated from P. roqueforti. It has nematocidal activity against the parasitic nematode H. contortus (LD99=0.06 μg/mL) and inhibits motility of adult worms (EC50=2 μM). Marcfortine A eliminates H. contortus, T. colubriformis, and O. ostertagi from experimentally infected jirds (ED95s=0.33, 0.11, and 2.5 mg/animal, respectively). It dose-dependently inhibits nicotine-induced calcium mobilization in SH-SY5Y and TE-671 cells expressing α3 subunit-containing human nicotinic acetylcholine receptors (nAChRs) and muscle-type nAChRs, respectively.
loading...
    loading...
Cat. No.: HY-167160
CAS No.: 790689-76-8
Target:  

TRP Channel

Research Areas:  

Neurological Disease

AZ12099548 is a TRPV1 antagonist. AZ12099548 inhibits both Capsaicin (HY-10448)- and low pH-induced calcium mobilization .
loading...
    loading...
Cat. No.: HY-103572R
CAS No.: 946619-21-2
Research Areas:  

Neurological Disease

MNI137 (Standard) is the analytical standard of MNI137 (HY-103572). This product is intended for research and analytical applications. MNI137 is a potent and selective negative allosteric modulator for group II mGluRs. MNI137 has IC50s values of 8.3 and 12.6 nM for human and rat mGlu2 inhibition of glutamate-induced calcium mobilization .
loading...
    loading...
Cat. No.: HY-W574030
CAS No.: 126727-03-5
Target:  

Neurotensin Receptor

Research Areas:  

Neurological Disease

Fmoc-DL-Leu-OH acts as a partial agonist of the neurotensin NTS1 receptor (NTS1R) with an EC50 of 215.50 μM. Fmoc-DL-Leu-OH triggers intracellular calcium mobilization, and its activity is blocked by selective NTS1R antagonists. Fmoc-DL-Leu-OH can be used in the research of schizophrenia .
loading...
    loading...
Cat. No.: HY-187353
CAS No.: 3129083-71-9
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT2A agonist-12 is a human 5-HT2A receptor agonist with an EC50 of 0.78 μM (in Chinese hamster ovary cells). 5-HT2A agonist-12 modulates intracellular calcium mobilization in cells expressing the human 5-HT2A receptor. 5-HT2A agonist-12 can be used in research related to depression .
loading...
    loading...